Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study

Ida Behrens, Saima Basit, Mads Melbye, Jacob A Lykke, Jan Wohlfahrt, Henning Bundgaard, Baskaran Thilaganathan, Heather A Boyd, Ida Behrens, Saima Basit, Mads Melbye, Jacob A Lykke, Jan Wohlfahrt, Henning Bundgaard, Baskaran Thilaganathan, Heather A Boyd

Abstract

Objectives To determine how soon after delivery the risk of post-pregnancy hypertension increases in women with hypertensive disorders of pregnancy and how the risk evolves over time.Design Nationwide register based cohort study.Setting Denmark.Populations 482 972 primiparous women with a first live birth or stillbirth between 1995 and 2012 (cumulative incidence analyses), and 1 025 118 women with at least one live birth or stillbirth between 1978 and 2012 (Cox regression analyses).Main outcome measures 10 year cumulative incidences of post-pregnancy hypertension requiring treatment with prescription drugs, and hazard ratios estimated using Cox regression.Results Of women with a hypertensive disorder of pregnancy in a first pregnancy in their 20s, 14% developed hypertension in the first decade post partum, compared with 4% of women with normotensive first pregnancies in their 20s. The corresponding percentages for women with a first pregnancy in their 40s were 32% and 11%, respectively. In the year after delivery, women with a hypertensive disorder of pregnancy had 12-fold to 25-fold higher rates of hypertension than did women with a normotensive pregnancy. Rates in women with a hypertensive disorder of pregnancy were threefold to 10-fold higher 1-10 years post partum and remained twice as high even 20 or more years later.Conclusions The risk of hypertension associated with hypertensive disorders of pregnancy is high immediately after an affected pregnancy and persists for more than 20 years. Up to one third of women with a hypertensive disorder of pregnancy may develop hypertension within a decade of an affected pregnancy, indicating that cardiovascular disease prevention in these women should include blood pressure monitoring initiated soon after pregnancy.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: IB and SB were supported by a grant from the Danish Council for Independent Research; IB also received grant support from the Danish Heart Association; no other support for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5506851/bin/behi038201.f1.jpg
Fig 1 Ten year cumulative incidences of hypertension by years since first pregnancy in women with and without a hypertensive disorder of pregnancy, by age at first delivery, Denmark, 1995-2012. Follow-up began in 1995 or three months post partum, whichever came later
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5506851/bin/behi038201.f2.jpg
Fig 2 Hazard ratios for hypertension by severity of hypertensive disorder of pregnancy (if any) in the most recent pregnancy and time since most recent pregnancy, among women with at least one live birth or stillbirth in Denmark, 1978-2012. Hazard ratios compare rates of hypertension among women with severe pre-eclampsia (orange), moderate pre-eclampsia (green), and gestational hypertension (black) in the latest pregnancy with rates of hypertension in women whose most recent pregnancy was normotensive. Follow-up began in 1995 or three months post partum, whichever came later. Hazard ratios are adjusted for maternal age, maternal birth year, and parity (see also supplementary figure 1 for corresponding figure with hypertensive disorders of pregnancy classified by timing of delivery)
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5506851/bin/behi038201.f3.jpg
Fig 3 Hazard ratios for hypertension by history of most severe hypertensive disorder of pregnancy and attained maternal age, among women with at least one live birth or stillbirth in Denmark, 1978-2012. Hazard ratios compare rates of hypertension among women with severe pre-eclampsia (orange), moderate pre-eclampsia (green), and gestational hypertension (black) as their most severe hypertensive disorder of pregnancy (cumulative history over all pregnancies) with rates of hypertension in women whose pregnancies were all normotensive. Follow-up began in 1995 or three months postpartum, whichever came later. Hazard ratios are adjusted for maternal age, maternal birth year, parity, and time since most recent pregnancy
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5506851/bin/behi038201.f4.jpg
Fig 4 Hazard ratios for hypertension by hypertensive disorder of pregnancy sequence in two first pregnancies by number of years since the second pregnancy, among women with at least two live births or stillbirths in Denmark, 1978-2012. Hazard ratios compare rates of hypertension among women with a hypertensive disorder of pregnancy in first pregnancy but not in the second (green), a normotensive first pregnancy followed by a hypertensive disorder of pregnancy in second pregnancy (red), and hypertensive disorders of pregnancy in two successive pregnancies (purple), with rates in women with two successive normotensive pregnancies. Follow-up began in 1995 or 3 months after the second delivery, whichever came later. Hazard ratios are adjusted for maternal age, maternal birth year, and parity

References

    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013;170:1-7. 10.1016/j.ejogrb.2013.05.005 .
    1. American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31..
    1. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974 10.1136/ .
    1. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944-51. 10.1161/HYPERTENSIONAHA.109.130765 .
    1. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013;28:1-19. 10.1007/s10654-013-9762-6 .
    1. Mosca L, Benjamin EJ, Berra K, et al. American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011;57:1404-23. 10.1016/j.jacc.2011.02.005 .
    1. Piepoli MF, Hoes AW, Agewall S, et al. Authors/Task Force Members. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;37:2315-81. 10.1093/eurheartj/ehw106 .
    1. Wilkins-Haug L, Celi A, Thomas A, Frolkis J, Seely EW. Recognition by womenʼs health care providers of long-term cardiovascular disease risk after preeclampsia. Obstet Gynecol 2015;125:1287-92. 10.1097/AOG.0000000000000856 .
    1. Young B, Hacker MR, Rana S. Physicians’ knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy 2012;31:50-8. 10.3109/10641955.2010.544955 .
    1. Heidrich M-B, Wenzel D, von Kaisenberg CS, Schippert C, von Versen-Höynck FM. Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know?BMC Pregnancy Childbirth 2013;13:61 10.1186/1471-2393-13-61 .
    1. National Collaborating Centre for Women’s and Children’s Health. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy.RCOG Press, 2011.
    1. Engeland A, Bjørge T, Klungsøyr K, Skjærven R, Skurtveit S, Furu K. Preeclampsia in pregnancy and later use of antihypertensive drugs. Eur J Epidemiol 2015;30:501-8. 10.1007/s10654-015-0018-5 .
    1. Veerbeek JHW, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 2015;65:600-6. 10.1161/HYPERTENSIONAHA.114.04850 .
    1. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014;29:541-9. 10.1007/s10654-014-9930-3 .
    1. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(Suppl):30-3. 10.1177/1403494811401482 .
    1. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45:320-3..
    1. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39(Suppl):38-41. 10.1177/1403494810394717 .
    1. Lin DY, Wei LJ, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993;80:557-72 10.1093/biomet/80.3.557.
    1. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007;166:117-24. 10.1093/aje/kwm139 .
    1. Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014;4:97-104..
    1. Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3:e003423 10.1136/bmjopen-2013-003423 .
    1. MacDonald SE, Walker M, Ramshaw H, Godwin M, Chen XK, Smith G. Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate?J Obstet Gynaecol Can 2007;29:705-10. 10.1016/S1701-2163(16)32601-9 .
    1. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009;114:961-70. 10.1097/AOG.0b013e3181bb0dfc .
    1. Nisell H, Lintu H, Lunell NO, Möllerström G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995;102:876-81. 10.1111/j.1471-0528.1995.tb10874.x .
    1. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845 10.1136/bmj.326.7394.845 .
    1. Egeland GM, Klungsøyr K, Øyen N, Tell GS, Næss Ø, Skjærven R. Preconception cardiovascular risk factor differences between gestational hypertension and preeclampsia: Cohort Norway Study. Hypertension 2016;67:1173-80. 10.1161/HYPERTENSIONAHA.116.07099 .
    1. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010;122:478-87. 10.1161/CIRCULATIONAHA.109.895458 .
    1. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents?Circulation 2010;122:579-84. 10.1161/CIRCULATIONAHA.110.943407 .
    1. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health?Epidemiol Rev 2014;36:57-70. 10.1093/epirev/mxt006 .
    1. Staff AC, Redman CWG, Williams D, et al. Global Pregnancy Collaboration (CoLab). Pregnancy and long-term maternal cardiovascular health: progress through harmonization of research cohorts and biobanks. Hypertension 2016;67:251-60..

Source: PubMed

3
Abonnere